The existence of bronchiectasis predicts worse prognosis in patients with COPD

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Mao, Bei ^a,b   Lu, Hai Wen ^a   Li, Man Hui ^a,b   Fan, Li Chao ^a   Yang, Jia Wei ^a,b   Miao, Xia Yi ^a   Xu, Jin Fu ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BRONCHIECTASIS; CHINA; COMPLICATION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; ISOLATION AND PURIFICATION; LUNG; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PATHOGENICITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDY; RISK FACTOR; SPUTUM; SURVIVAL ANALYSIS;

AGED; BRONCHIECTASIS; CHINA; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; LUNG; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; SPUTUM; SURVIVAL ANALYSIS;

EID: 84935890279     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10961     Document Type: Article

References (34)

1. Landis S. H., Muellerova H. & Mannino D. M. et al. Continuing to confront COPD international patient survey: methods, COPD prevalence, and disease burden in 2012-2013. Int J Chron Obstruct Pulmon Dis 9, 597-611 (2014).
2. Wali S. O., Idrees M. M. & Alamoudi O. S. et al. Prevalence of chronic obstructive pulmonary disease in Saudi Arabia. Saudi Med J 35, 684-90 (2014).
3. El Hasnaoui A., Rashid N. & Lahlou A. et al. Chronic obstructive pulmonary disease in the adult population within the Middle East and North Africa region: rationale and design of the BREATHE study. Respir Med 106, S3-15 (2012).
4. Waked M., Khayat G. & Salameh P. Chronic obstructive pulmonary disease prevalence in Lebanon: a cross-sectional descriptive study. Clin Epidemiol 3, 315-23 (2011).
5. Cai L. 1., Cui W. & He J. et al. The economic burden of smoking and secondhand smoke exposure in rural South-West China. J Asthma 51, 515-21 (2014).
6. Kim C., Yoo K. H. & Rhee C. K. et al. Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea. Int J Tuberc Lung Dis 18, 737-43 (2014).
7. Slok A. H., in't Veen J. C. & Chavannes N. H. et al. Development of the assessment of burden of COPD tool: an integrated tool to measure the burden of COPD. NPJ Prim Care Respir Med 24, 14021 (2014).
8. Peian Lou, Yanan Zhu & Peipei Chen et al. Vulnerability, beliefs, treatments and economic burden of chronic obstructive pulmonary disease in rural areas in China: a cross-sectional study. BMC Public Health 12, 287 (2012).
9. O'Brien C. O., Guest P. J. & Hill S. L. et al. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 55, 635-642 (2000).
10. Patel I. S., Vlahos I. & Wilkinson T. M. et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170, 400-407 (2004).
11. Martínez-García M. Á., Soler-Cataluña J. J. & Donat Sanz Y. et al. Factors associated with bronchiectasis in patients with COPD. CHEST 140, 1130-1137 (2011).
12. Martínez-García M. A., de la Rosa Carrillo D. & Soler-Cataluña J. J. et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187, 823-31 (2013).
13. Rabe K. F., Hurd S. & Anzueto A. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 532-555 (2007).
14. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 117, 398S-401S (2000).
15. Burge S. & Wedzicha J. A. COPD exacerbations: definitions and classifications. Eur Respir J Suppl 41, 46s-53s (2003).
16. Celli B. R. & Barnes P. J. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 29, 1224-38 (2007).
17. Naidich D. P., McCauley D. I. & Khouri N. F. et al. Computed tomography of bronchiectasis. J ComputAssist Tomogr 6, 437-444 (1982).
18. Lynch D. A., Newell J. D. & Tschomper B. A. et al. Uncomplicated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology 188, 829-833 (1993).
19. Burt M. G., Roberts G. W. & Aguilar-Loza N. R. et al. Relationship between glycaemia and length of hospital stay during an acute exacerbation of chronic obstructive pulmonary disease. Intern Med J 43, 721-4 (2013).
20. Koskela H. O., Salonen P. H. & Niskanen L. Hyperglycaemia during exacerbations of asthma and chronic obstructive pulmonary disease. Clin Respir J 7, 382-9 (2013).
21. Parappil A., Depczynski B. & Collett P. et al. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology 15, 918-22 (2010).
22. Küpeli E., Ulubay G. & Ulasli S. S. et al. Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study. Endocrine 38, 76-82 (2010).
23. Murphy T. F., Brauer A. L. & Schiffmacher A. T. et al. Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170, 266-272 (2004).
24. Chin C. L., Manzel L. J. & Lehman E. E. et al. Haemophilus influenza from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers. Am J Respir Crit Care Med 172, 85-91 (2005).
25. Sethi S., Evans N. & Grant B. J. et al. New strains of bacteria and exacerbation of chronic obstructive pulmonary disease. N Engl J Med 347, 465-471 (2002).
26. Garcia Vidal C., Almagro P. & Romani V. et al. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbations: a prospective study. Eur Respir J 34, 1072-1078 (2009).
27. King P. Pathogenesis of bronchiectasis. Paediatr Respir Rev 12, 104-10 (2011).
28. Guilemany J. M., Mullol J. & Picado C. Relation between rhinosinusitis and bronchiectasis. Arch Bronconeumol 42, 135-40 (2006).
29. Garcia-Vidal C. 1., Almagro P. & Romaní V. et al. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study. Eur Respir J 34, 1072-1078 (2009).
30. Habesoglu M. A., Ugurlu A. O. & Eyuboglu F. O. Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis. Ann Thorac Med 6, 131-6 (2011).
31. Soler-Cataluña J. J., Martínez-García M. A. & Román Sánchez P. et al. Severe acute exacerbations and mortality in patients with obstructive pulmonary disease. Thorax 60, 925-931 (2005).
32. Stiell I. G., Clement C. M. & Aaron S. D. et al. Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study. CMAJ 186, E193-204 (2014).
33. Sethi S., Evans N. & Grant B. J. et al. New strains of bacteria and exacerbation of chronic obstructive pulmonary disease. N Engl J Med 347, 465-471 (2002).
34. Rosell A., Monsó E. & Soler N. et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 165, 891-7 (2005).